EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
2019 · European Urology · 190 citations
https://doi.org/10.1016/j.eururo.2019.09.035
M
Michael Rink
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
551
Papers
12.2K
Citations
58
h-index
214
i10-index
Michael Rink is an academic researcher from Marienkrankenhaus Hamburg. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Urological Disorders and Treatments. The author has an h-index of 58, co-authored 469 publications.
ORCID: 0000-0001-5403-7915Papers by this author
worksPrognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
2012 · European Urology · 184 citations
https://doi.org/10.1016/j.eururo.2012.01.017
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
2019 · Annals of Oncology · 180 citations
https://doi.org/10.1093/annonc/mdz296
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
2025 · European Urology · 98 citations
https://doi.org/10.1016/j.eururo.2025.02.019
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
2016 · World Journal of Urology · 31 citations
https://doi.org/10.1007/s00345-016-1835-1
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
2021 · World Journal of Urology · 26 citations
https://doi.org/10.1007/s00345-020-03586-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat